Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL658049 | 0.85 | MAPT (0.59) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL31601639 | 0.84 | SMN1; SMN2 (0.55) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL13948407 | 0.84 | MAPT (0.57) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL5184390 | 0.84 | SMN1; SMN2 (0.55) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL28466046 | 0.83 | MAPT (0.47) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL16980499 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2POLBKMT2AMEN1GAA | |
| SCHEMBL28470217 | 0.82 | MAPT (0.66) | SMN1; SMN2POLBALDH1A1KMT2AGAA | |
| SCHEMBL4824629 | 0.82 | SMN1; SMN2 (0.54) | SMN1; SMN2POLBALDH1A1KMT2AGAA | |
| SCHEMBL31033400 | 0.82 | SMN1; SMN2 (0.54) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 | |
| SCHEMBL26251369 | 0.82 | HPGD (0.63) | SMN1; SMN2POLBALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111690695-A | Enzymatic microfluidic online synthesis method of 3-phenylaminopropylhydroxamic acid | 浙江工业大学 | 2020-09-22 | — | — | CN | disclosed |
| US-20130096334-A1 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst | The United States of America as represented by the Administrator of the United States Environment Pr (US) | 2013-04-18 | — | — | US | disclosed |
| US-20130096334-A1 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst | The United States of America as represented by the Administrator of the United States Environment Pr (US) | 2013-04-18 | — | — | US | disclosed |
| US-8324125-B2 | Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY (US) | 2012-12-04 | — | — | US | disclosed |
| US-8324125-B2 | Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY (US) | 2012-12-04 | — | — | US | disclosed |
| US-20110054180-A1 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst | USA as Represented by the Administrator of U.S. Environmental Protection Agency (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110054180-A1 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst | USA as Represented by the Administrator of U.S. Environmental Protection Agency (US) | 2011-03-03 | — | — | US | disclosed |
| WO-2009127815-A1 | AMINOALYL-IMIDAZOTETRAZINES FOR TREATMENT OF CANCER | THE UNIVERSITY OF BRADFORD (GB) | 2009-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054180-A1 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst | GSTK1, GSTA1, GSTP1 | SMN1; SMN2 4528/4885POLB 3547/4885ALDH1A1 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.